Back to Search
JACOB KARP, PHARMD
PHARMD
Pharmacist
NPI: 1326754524Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
86332(CA)
Research & Publications (20)
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.
PMID 19109557·Blood·2009
3-trial
Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.
PMID 18483374·Clin Cancer Res·2008
3-trial
A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders.
PMID 17640728·Leuk Res·2008
3-trial
Integrated diffractive shearing interferometry for adaptive wavefront sensing.
PMID 19079478·Appl Opt·2008
8-other
Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells.
PMID 17538722·Lab Chip·2007
8-other
Development and therapeutic applications of advanced biomaterials.
PMID 17981454·Curr Opin Biotechnol·2007
6-review
Development of farnesyltransferase inhibitors for clinical cancer therapy: focus on hematologic malignancies.
PMID 17882662·Cancer Invest·2007
6-review
Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia.
PMID 17671131·Clin Cancer Res·2007
3-trial
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
PMID 17562873·Blood·2007
3-trial
Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro.
PMID 16253980·Stem Cells·2006
8-other
A photolithographic method to create cellular micropatterns.
PMID 16730059·Biomaterials·2006
7-preclinical
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
PMID 16322302·Clin Cancer Res·2005
3-trial
Targeting the process of farynesylation for therapy of hematologic malignancies.
PMID 16305490·Curr Mol Med·2005
6-review
Farnesyl transferase inhibition in hematologic malignancies.
PMID 16280111·J Natl Compr Canc Netw·2005
8-other
Development of the farnesyltransferase inhibitor tipifarnib for therapy of hematologic malignancies.
PMID 16556050·Future Oncol·2005
6-review
Pain predicts longer time to remission during treatment of recurrent depression.
PMID 15889945·J Clin Psychiatry·2005
4-observational
Trying to improve clinical outcome in AML: lessons from negative trials.
PMID 15863196·Leuk Res·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13650 BEAR VALLEY RD
VICTORVILLE, CA 92392 - Phone
- (760) 243-4595
Quick Facts
- NPI
- 1326754524
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile